Susquehanna International Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.8M Buy
2,815,304
+2,143,611
+319% +$16.6M 0.03% 1876
2025
Q4
$5.24M Buy
671,693
+425,932
+173% +$3.08M 0.01% 3942
2025
Q3
$1.87M Sell
245,761
-158,770
-39% -$1.32M ﹤0.01% 5941
2025
Q2
$3.62M Buy
404,531
+7,669
+2% +$71.4K 0.01% 4592
2025
Q1
$2.98M Buy
396,862
+171,162
+76% +$1.38M ﹤0.01% 4667
2024
Q4
$1.7M Sell
225,700
-9,166
-4% -$69.6K ﹤0.01% 5679
2024
Q3
$1.78M Sell
234,866
-41,485
-15% -$315K ﹤0.01% 5508
2024
Q2
$1.71M Sell
276,351
-840,606
-75% -$4.64M ﹤0.01% 5403
2024
Q1
$5.67M Buy
1,116,957
+782,090
+234% +$4.4M 0.01% 3447
2023
Q4
$2.01M Buy
334,867
+15,250
+5% +$88.4K ﹤0.01% 5340
2023
Q3
$2.26M Sell
319,617
-98,664
-24% -$709K ﹤0.01% 4885
2023
Q2
$2.94M Sell
418,281
-152,426
-27% -$1.22M ﹤0.01% 4402
2023
Q1
$4.76M Buy
570,707
+36,467
+7% +$351K 0.01% 3543
2022
Q4
$6.13M Sell
534,240
-413,189
-44% -$5.15M 0.01% 2920
2022
Q3
$11.9M Sell
947,429
-74,947
-7% -$965K 0.02% 1937
2022
Q2
$10.8M Sell
1,022,376
-217,375
-18% -$2.24M 0.02% 2110
2022
Q1
$20.2M Sell
1,239,751
-756,233
-38% -$12.1M 0.03% 1722
2021
Q4
$27.6M Buy
1,995,984
+263,742
+15% +$3.49M 0.04% 1544
2021
Q3
$24.9M Buy
1,732,242
+90,292
+5% +$1.42M 0.03% 1751
2021
Q2
$26M Sell
1,641,950
-452,495
-22% -$6.15M 0.03% 1761
2021
Q1
$21.3M Buy
2,094,445
+50,462
+2% +$520K 0.03% 1795
2020
Q4
$15.2M Buy
2,043,983
+726,520
+55% +$3.75M 0.02% 2024
2020
Q3
$4.53M Sell
1,317,463
-102,524
-7% -$439K 0.01% 3187
2020
Q2
$6.77M Buy
1,419,987
+1,029,620
+264% +$4.11M 0.01% 2612
2020
Q1
$781K Buy
390,367
+278,842
+250% +$768K ﹤0.01% 5940
2019
Q4
$385K Sell
111,525
-33,363
-23% -$83.9K ﹤0.01% 7506
2019
Q3
$415K Sell
144,888
-309,811
-68% -$964K ﹤0.01% 7677
2019
Q2
$1.72M Buy
+454,699
New +$2.74M ﹤0.01% 4470
2019
Q1
Hold
0
8896
2018
Q4
Hold
0
9008
2018
Q3
Hold
0
9272
2018
Q2
Hold
0
9652
2018
Q1
Hold
0
9357
2017
Q4
Sell
-38,923
Closed -$189K 9290
2017
Q3
$204K Buy
+38,923
New +$199K ﹤0.01% 7984
2017
Q2
Sell
-60,589
Closed -$369K 9229
2017
Q1
$509K Sell
60,589
-309,827
-84% -$2.16M ﹤0.01% 6455
2016
Q4
$2.35M Buy
370,416
+257,615
+228% +$1.34M 0.01% 3731
2016
Q3
$497K Buy
112,801
+25,561
+29% +$102K ﹤0.01% 6057
2016
Q2
$248K Sell
87,240
-42,174
-33% -$131K ﹤0.01% 7269
2016
Q1
$366K Sell
129,414
-29,846
-19% -$132K ﹤0.01% 6925
2015
Q4
$1.64M Buy
159,260
+7,020
+5% +$69.8K ﹤0.01% 4431
2015
Q3
$1.74M Buy
152,240
+122,312
+409% +$1.63M ﹤0.01% 4550
2015
Q2
$447K Buy
29,928
+16,014
+115% +$182K ﹤0.01% 7841
2015
Q1
$126K Sell
13,914
-70,312
-83% -$728K ﹤0.01% 8879
2014
Q4
$1.02M Buy
+84,226
New +$930K ﹤0.01% 5834
2014
Q3
Sell
-58,342
Closed -$715K 9421
2014
Q2
$744K Sell
58,342
-216,325
-79% -$2.1M ﹤0.01% 6675
2014
Q1
$2.91M Buy
+274,667
New +$2.93M 0.01% 3703
2013
Q4
Hold
0
8976
2013
Q3
Sell
-325,300
Closed -$1.65M 8411
2013
Q2
$504K Buy
+325,300
New +$561K ﹤0.01% 6022

Other funds holding BCRX